Zack Bozinovski
Wellnex Life
Andrew Chapman
Merchant Funds Management
Shane Duncan
Cann Group
George Karafotias
Wellnex Life
Dr Anubhav Saxena
Bell Potter
Patrick Nelson
Reach Markets
About the Summit
Medicinal cannabis is gaining traction among patients and practitioners as a viable form of treatment for a range of conditions. The TGA’s decision to greenlight the sale of medicinal cannabis products over the counter in pharmacies could potentially cause the market to boom, thus sparking investor interest. In this two-part The Insider: Future of Medicinal Cannabis Summit, hosted by Reach Markets MD Patrick Nelson, we have industry insiders and experts sharing first-hand insights on Australia’s emerging medicinal cannabis industry, how investors can take advantage of the opportunities it brings and some of the companies positioned to be top performers.
Session 1
In the first session, featured speakers Zack Bozinovski, CSO of Wellnex Life Limited (ASX: WNX) and Shane Duncan, COO of Cann Group Limited (ASX: CAN) discussed:
- How the TGA’s ruling can proliferate medicinal cannabis use in Australia
- The challenges and potential rewards for business aiming to be first-to-market
- How their companies are positioned to lead the emerging market
Recorded on 13th October 2022 at 12pm (AEDT).
Session 1 breakdown
A key regulatory ruling is expected to normalise the use of medicinal cannabis in Australia and enable the market to flourish. Learn about the challenges and rewards this holds for the businesses that are first-to-market.
21st October, 2022
A health and wellness business and potential first-mover in over-the-counter medicinal cannabis sizes itself up against the opportunity, and highlights why it holds certain advantages over its competitors in the sector.
21st October, 2022
A medicinal cannabis pioneer and heavyweight breaks down its recent business growth, highlights the advantages of being a cannabis manufacturer, and outlines its successes abroad while revealing its plans for Australia.
21st October, 2022
Session 2
In the second session, featured speakers Dr Anubhav Saxena, Healthcare Equities Analyst at Bell Potter, Andrew Chapman, MD of Merchant Funds management and George Karafotias, CEO of Wellnex Life Limited (ASX: WNX) discussed:
- How medicinal cannabis has earned favour among consumers and regulators
- The key drivers in the market and how businesses can take advantage
- Three companies to watch closely as the market unfolds
Recorded on 4th November 2022 at 12pm (AEDT).
Session 2 breakdown
Industry insiders discuss the emergence of the medicinal cannabis industry in Australia, highlighting how the sector is gaining support on several fronts, both commercial and medical, and how it has evolved from ‘dreadlocks’ to ‘suits’.
21st October, 2022
The panel discusses key drivers in the market, how the market is evolving, why patient demand is significant and growing, and how the TGA ruling can lead to educating consumers by building awareness through increased access.
21st October, 2022
Our speakers highlight their favourite stocks including a medicinal cannabis business with an innovative platform, a German-based company nearing an IPO on the ASX and a health and wellness business shaping up to be a dark horse.
21st October, 2022
Related Articles
Wellnex Life (ASX: WNX) Webcast Replay
Unlocking the over-the-counter medicinal cannabis opportunity
Wellnex Life CEO George Karafotias and Chief Strategy Officer Zack Bozinovski provide an overview of the over-the-counter medicinal cannabis opportunity in a special investor briefing, they discussed:
- Why over-the-counter medicinal cannabis is seen as one of the biggest opportunities in Australian pharma in recent times
- How Wellnex is positioned to be one of the front runners and market leaders in the space
- Why medicinal cannabis is a game-changer in the treatment of chronic pain, inflammation and sleep deprivation
Recorded on 14th October 2022 at 12pm (AEST).
Speakers
Zack Bozinovski
CSO - Wellnex Life
Zack is a highly successful and seasoned executive in the Australian retail industry with over 35 years’ experience within FMCG and Pharmaceutical companies in Australia and internationally. Zack has previously held senior positions at Uncle Tobys/Goodman Fielder, PepsiCo and Sigma and successfully developed and established many brands in the Australian retail sector. Zack most recently held the position of Managing Director at Brands Solutions Australia. Zack was also a co-founder of Voost Vitamins, recently sold to Proctor & Gamble. Read More
Shane Duncan
COO - Cann Group
Shane is a broadly skilled consumer healthcare, medical device and pharmaceutical sales and marketing executive with a proven record of launching, establishing, and growing businesses, brands and commercial opportunities. He also has extensive global experience in strategy development, pre-commercialisation planning and product launch execution and currently oversees the commercial, cultivation, manufacturing and R&D programs for Cann Group.
Read More
Dr Anubhav Saxena
Healthcare Equities Analyst - Bell Potter
Dr Anubhav Saxena, Healthcare Equities Analyst at Bell Potter, has conducted and released in-depth research into Australia’s biotech and medicinal cannabis industries and has helped facilitate successful buy-recommendations for companies operating within both industries.
Read More
Andrew Chapman
Managing Director - Merchant Funds Management
Andrew Chapman, Managing Director of Merchant Funds Management, has market-tested knowledge on active portfolio management and risk. His objective is to take the expertise he has gained over 20-plus years of managing the investments of the uber-wealthy and work to make those opportunities available to all.
Read More
George Karafotias
CEO - Wellnex Life
George has a lengthy track record in listed companies, holding various senior executive roles. He has had success in restructuring and reinventing ASX-listed companies and implementing turnaround strategies, as demonstrated with Wellnex. George further served as a non-executive Director of Perpetual Resources Limited (ASX: PEC) for around a decade and holds a Bachelor of Commerce degree from the University of Adelaide. Read More
Patrick Nelson
Managing Director - Reach Markets
For over a decade Patrick ran one of Australia’s busiest full-service options desks. In 2018 he founded Reach Markets, which is one of the fastest growing corporate finance & IR firms in Australia. Patrick is an education partner for options trading to the ASX but first and foremost he is a passionate trader and investor who manages his own portfolio.
Read More
Reach Corporate provide Corporate Advisory Services to WNX and have been engaged by them to manage their investor communications.
The Insider Summit Series
Upcoming Session
The Insider Summit Series
Get access to industry leaders providing valuable insights on the key industries, investment trends and how to identify potential opportunities.
In this session they will discuss:
- An industry overview
- A market outlook
- Key stocks in the sector
This is a live and interactive online session, and participants are encouraged to ask questions. Spots are limited, so secure yours today.
Book into the next session
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.